Home monitoring in interstitial lung diseases
File(s)
Author(s)
Type
Journal Article
Abstract
The widespread use of smartphones and the internet has enabled self-monitoring and more hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring, including in the heterogenous and often vulnerable group of patients with interstitial lung diseases (ILDs). Home monitoring in ILD has the potential to improve access to specialist care, reduce the burden on health-care systems, improve quality of life for patients, identify acute and chronic disease worsening, guide treatment decisions, and simplify clinical trials. Home spirometry has been used in ILD for several years and studies with other devices (such as pulse oximeters, activity trackers, and cough monitors) have emerged. At the same time, challenges have surfaced, including technical, analytical, and implementational issues. In this Series paper, we provide an overview of experiences with home monitoring in ILD, address the challenges and limitations for both care and research, and provide future perspectives. VIDEO ABSTRACT.
Date Issued
2023-01
Date Acceptance
2022-06-08
Citation
The Lancet Respiratory Medicine, 2023, 11 (1), pp.97-110
ISSN
2213-2600
Publisher
Elsevier
Start Page
97
End Page
110
Journal / Book Title
The Lancet Respiratory Medicine
Volume
11
Issue
1
Copyright Statement
© 2022 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/36206780
PII: S2213-2600(22)00228-4
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2022-10-04